Bayer - 24 Year Stock Split History | BAYRY

Stock split history for Bayer since 2001. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Bayer Annual Stock Splits
Bayer Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $31.359B $50.438B
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $751.564B 57.63
Johnson & Johnson (JNJ) United States $377.513B 15.61
AbbVie (ABBV) United States $339.944B 18.74
Novo Nordisk (NVO) Denmark $307.772B 20.39
Roche Holding AG (RHHBY) Switzerland $258.243B 0.00
Novartis AG (NVS) Switzerland $255.645B 14.60
Merck (MRK) United States $209.320B 10.70
Pfizer (PFE) United States $145.830B 7.99
Sanofi (SNY) France $119.214B 11.74
Innoviva (INVA) United States $1.178B 12.35